Novo Seeds invests in Dutch biotech firm with NASH focus again
For the third time, Novo Holding's venture arm Novo Seeds has invested in biotech company Northsea Therapeutics. This will allow the latter to start a phase III study of a candidate within NASH and continue phase I and II studies of other candidates.
by albert rønning-andersson, translated by catherine brett
Novo Seeds, the department of Novo Holdings which works with early investments, has expressed confidence in Northsea Therapeutics by investing in it for the third time.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg&w=384&q=75)
